Implementation of Nutrition Education Videos for Patients Undergoing Radical Cystectomy

Overview

By doing this study the investigators hope to learn if educational videos focusing on nutrition for bladder cancer patients are a good and effective way to help people improve their nutrition and recovery after radical cystectomy (RC).

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2021

Detailed Description

Bladder Cancer is the fifth most common cancer in the USA. The primary treatment for invasive bladder cancer is chemotherapy followed by RC. Patients undergoing this surgery are at risk for complications. Being malnourished can increase the risk of mortality by three times. The patients also suffer from taste alterations after chemotherapy and gastrointestinal disturbances such as diarrhea and constipation. These can lead to poor nutritional intake and malabsorption of nutrients. This study is being done to develop an educational video series for patients undergoing RC and assess their impact. The videos are created to address the nutritional needs of these patients and improve their outcomes after surgery.

Interventions

  • Behavioral: Educational Videos
    • 15 videos that are about 3 minutes long each and cover nutritional advice for patients with bladder cancer undergoing RC and/or chemotherapy.

Arms, Groups and Cohorts

  • RC Patients
    • Patients at the University of Kansas Medical Center who have not yet had their radical cystectomy, after their radical cystectomy, or between the completion of chemotherapy and the radical cystectomy.

Clinical Trial Outcome Measures

Primary Measures

  • Evaluate content of three educational video series
    • Time Frame: Week 2
    • Evaluate the content of three video series focusing on practical solutions to nutritional problems common to patients undergoing a radical cystectomy through iterative process using Center for Disease Control’s Clear Communication Index. The Center for Disease Control’s Clear Communication Index uses 4 questions and 20 scored items to asses how materials enhance and aid people’s understanding of information in seven areas – main message and call to action, language, information design, state of the science, behavioral recommendations, numbers, and risk. The range of scores is 0 to 100 with a score of 90 or higher considered a passing score.
  • Patient Feedback Regarding Videos
    • Time Frame: Week 2
    • After viewing the videos semi-structure interviews of participants will be conducted to obtain feedback regarding the videos content and design.
  • Patient Attention During Videos
    • Time Frame: Week 2
    • Eye tracking of participants will be used to assess attention of participants during the videos in order to best understand how participants are viewing the videos and responding to them.
  • Test feedback instrument with patients
    • Time Frame: Week 2
    • Use a pretest developed instrument measuring nutrition knowledge to test participants knowledge before and after watching the videos
  • Assess implantation of video series
    • Time Frame: Week 2
    • Online survey of viewers will be used to gain feedback on how the videos were received by those who watched them

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosed with bladder cancer and scheduled to undergo a radical cystectomy or has undergone a radical cystectomy OR be the caregiver of a patient diagnosed with bladder cancer who is scheduled to undergo a radical cystectomy or has undergone a radical cystectomy Exclusion Criteria:

  • 1. Patients who are under 18 years old are not allowed to participate

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Kansas Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Eugene Lee, MD, Principal Investigator, University of Kansas Medical Center
  • Overall Contact(s)
    • Katie Glavin, 913-588-8721, kglavin@kumc.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.